欧辛诺菲尔性粒状瘤与蒙特卢卡斯特引起的多边膜炎
Paul Grama1, Corina Ureche1, Corina Adelina Zah2
1George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, First Internal Medical Department, Târgu Mureș, Romania.
Acta clinica Croatica
|February 17, 2025
概括
蒙特卢卡斯特是一种常见的喘药物,很少会导致带有多炎 (EGPA) 的eosinophilic granulomatosis. 医生应考虑在症状恶化的患者中进行这种诊断,因为治疗往往会带来良好的结果.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胰岛素受体对抗剂 (LTRAs) 广泛用于喘维持治疗.
- 带有多炎 (EGPA) 的埃索诺菲尔颗粒炎是一种罕见但严重的不良反应,与LTRA相关,特别是蒙特卢卡斯特.
- EGPA呈现为血管炎,严重的喘,和eosinophilia,需要迅速识别.
研究的目的:
- 要强调诊断蒙特卢卡斯特诱导的EGPA的重要性.
- 分析已发表的蒙特卢卡斯特诱导的EGPA病例的具体特征.
- 提高专家对这种不良药物事件的认识.
主要方法:
- 对蒙特卢卡斯特诱导的EGPA发表的病例报告进行系统的审查和分析.
- 确定临床表现,患者人口统计和治疗结果.
- 与其他药物诱导的EGPA发生率的比较.
主要成果:
- 与其他药物诱导的EGPA相比,蒙特卢卡斯特诱导的EGPA是一个显著的不良事件.
- 超过一半的受影响患者是女性.
- 神经病变是最常见的临床表现.
- 在蒙特卢卡斯特开始和EGPA开始之间观察到可变的时间间隔.
- 大多数患者在免疫抑制药物治疗中取得了良好的结果.
结论:
- 蒙特卢卡斯特诱导的EGPA是一个关键的诊断,应考虑在蒙特卢卡斯特喘患者中经历症状恶化.
- 医生应该在这个患者群体中保持对EGPA的高度怀疑指数.
- 早期诊断和适当的免疫抑制治疗对于有利的患者结果至关重要.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
231
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
231
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
339
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
339
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


